Guy Martin has been a journalist since 2008.
He writes about all areas of pharma and biotech, and related business news.
He has a special interest in emerging technologies leading to the development of personalized medicines, along with the changes this will bring to the pharmaceutical industry and beyond.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze